person

Marta L.

Country
Belgium
Department
Neurology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 28 partner sites.

Specializations

Cardiovascular and Cerebrovascular Therapeutics

The investigator focuses on stroke and related vascular events.

  • Ischemic stroke prevention
  • Atrial fibrillation management
  • Atherosclerotic cardiovascular disease
  • Cardiac arrest outcomes
  • Heart failure treatment

Research aims to reduce morbidity from vascular insults.

Neurological Degeneration and Movement Disorders

Work includes progressive disorders such as Parkinson's disease and related movement impairments.

  • Parkinson's disease motor fluctuations
  • Multiple sclerosis disease-modifying therapy
  • Status epilepticus after cardiac arrest
  • Comatose post‑cardiac arrest care
  • Seizure suppression strategies

Efforts target preservation of neuronal integrity.

Psychiatric and Mood Disorders

Investigator evaluates treatments for persistent Major Depressive Disorder with anhedonia.

  • Adjunctive therapy for treatment‑resistant depression
  • Relapse prevention in depressive disorders
  • Anhedonia reduction strategies
  • Depression in comorbid cardiovascular patients
  • Psychiatric outcomes in chronic disease

Goal is to improve affective resilience.

Immunologic and Inflammatory Conditions

Research addresses disorders driven by immune dysregulation such as systemic mastocytosis.

  • Indolent systemic mastocytosis therapy
  • Non‑advanced mastocytosis disease control
  • Ulcerative colitis remission induction
  • Endometriosis‑related pelvic pain management
  • Inflammatory bowel disease outcomes

Studies aim to modulate pathogenic cytokine pathways.

Renal and Metabolic Disease Therapeutics

Focus includes Chronic Kidney Disease and associated metabolic risk.

  • Cardiovascular outcomes in end‑stage kidney disease
  • LDL‑cholesterol lowering in atherosclerosis
  • SGLT2‑inhibitor combinations for heart failure
  • Renal protection in vascular disease
  • Metabolic syndrome impact on cardiovascular health

Aim to attenuate progression of renal impairment.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.